Concurrent Investment Advisors LLC bought a new position in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) during the 4th quarter, HoldingsChannel reports. The fund bought 1,422 shares of the health services provider’s stock, valued at approximately $255,000.
A number of other hedge funds also recently modified their holdings of the stock. Choreo LLC lifted its position in Universal Health Services by 3.4% during the fourth quarter. Choreo LLC now owns 1,822 shares of the health services provider’s stock worth $325,000 after purchasing an additional 60 shares during the period. Empirical Finance LLC lifted its holdings in shares of Universal Health Services by 1.1% during the 3rd quarter. Empirical Finance LLC now owns 5,704 shares of the health services provider’s stock worth $1,306,000 after acquiring an additional 64 shares during the period. US Bancorp DE boosted its position in shares of Universal Health Services by 3.0% during the 3rd quarter. US Bancorp DE now owns 2,238 shares of the health services provider’s stock worth $512,000 after acquiring an additional 65 shares in the last quarter. Quarry LP increased its stake in Universal Health Services by 14.4% in the third quarter. Quarry LP now owns 516 shares of the health services provider’s stock valued at $118,000 after acquiring an additional 65 shares during the last quarter. Finally, Stratos Wealth Partners LTD. raised its position in Universal Health Services by 2.2% during the fourth quarter. Stratos Wealth Partners LTD. now owns 3,060 shares of the health services provider’s stock valued at $549,000 after purchasing an additional 65 shares in the last quarter. Institutional investors own 86.05% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages have weighed in on UHS. The Goldman Sachs Group downgraded Universal Health Services from a “buy” rating to a “neutral” rating and reduced their target price for the company from $228.00 to $198.00 in a report on Monday, December 16th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $226.00 price objective on shares of Universal Health Services in a research note on Tuesday, December 17th. TD Cowen lowered their target price on Universal Health Services from $275.00 to $251.00 and set a “buy” rating for the company in a research note on Tuesday, November 26th. Wells Fargo & Company reduced their price target on shares of Universal Health Services from $285.00 to $230.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Finally, Bank of America initiated coverage on shares of Universal Health Services in a research report on Wednesday, November 6th. They set a “neutral” rating and a $223.00 price objective for the company. Six investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $226.14.
Universal Health Services Price Performance
Shares of NYSE:UHS opened at $189.30 on Wednesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.28 and a current ratio of 1.39. Universal Health Services, Inc. has a 52 week low of $152.68 and a 52 week high of $243.25. The firm has a market cap of $12.49 billion, a PE ratio of 12.59, a price-to-earnings-growth ratio of 0.53 and a beta of 1.30. The firm’s fifty day moving average is $184.35 and its 200-day moving average is $205.64.
Universal Health Services Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend is Monday, March 3rd. Universal Health Services’s payout ratio is presently 5.32%.
Insider Buying and Selling at Universal Health Services
In other news, Director Maria Ruderman Singer sold 1,614 shares of the firm’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $191.15, for a total transaction of $308,516.10. Following the completion of the transaction, the director now directly owns 5,879 shares in the company, valued at $1,123,770.85. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 16.10% of the company’s stock.
Universal Health Services Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Recommended Stories
- Five stocks we like better than Universal Health Services
- ETF Screener: Uses and Step-by-Step Guide
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Should You Invest in Penny Stocks?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Compound Interest and Why It Matters When Investing
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS – Free Report).
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.